sdbn.org

Bayer CropScience said Wednesday that a West Virginia plant will reduce its storage of a toxic chemical that was in danger of being released in a deadly explosion nearly a year ago. More...

Biotechnology company Dyax Corp. said Wednesday it received a $1.5 million payment as Eli Lilly & Co. moved a potential leukemia treatment into early-stage clinical trials. More...

The Food and Drug Administration is warning consumers to avoid certain vials of insulin made by Novo Nordisk that were stolen earlier this year and may not be safe for use. More...

ISTA Pharmaceuticals Inc. on Wednesday reported successful late-stage clinical trial results for Xibrom QD, a new once-per-day eye drug. More...

Three months after a contentious proxy battle resulted in the ouster of its chairman, the board of directors at San Diego's Amylin Pharmaceuticals has picked a new chairman: Paulo Costa, who formerly headed the U.S. operations of biotech giant Novartis. More...

San Diego's Ligand Pharmaceuticals yesterday agreed to buy Neurogen, a Connecticut company that develops drugs for psychiatric and neurological disorders. More...

Shares of Ireland's Warner Chilcott Plc skyrocketed Monday on news of its bid to morph from a small, specialty pharmaceutical company to a global player by buying Procter & Gamble Co.'s prescription drug business for $3.1 billion. More...

The Food and Drug Administration is investigating reports of liver damage in patients taking alli, the only nonprescription weight loss drug approved by the agency. More...

Biovail Corp. said Monday it bought a drug intended to treat muscle movements caused by Parkinson's disease drugs, and will pay up to $192 million and potential royalties for the product. More...

Ligand Pharmaceuticals Inc. said Monday it has agreed to buy Neurogen for $11 million in stock as well as certain future cash payments based on licensing deals, real estate sales and other milestones. More...